loading

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) Forecast

The Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.4212, representing a +1,276% increase from the current price of $0.0306. The highest analyst price target is $0.559, and the lowest is $0.2834.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LVCLY Price Target
Average 0.4892 (+1,499% Upside)
loading

Long-term LVCLY price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Algorae Pharmaceuticals Ltd Sponsored ADR financial reports and earnings history, Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) stock could reach $1.0998 by 2030, $2.6863 by 2040 and $4.3388 by 2050. See the projected annual prices until 2050 of the Algorae Pharmaceuticals Ltd Sponsored ADR stock below:

  • Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) is expected to reach an average price of $1.8522 in 2035, with a high prediction of $1.8522 and a low estimate of $1.5893. This indicates an $5,953% rise from the last recorded price of $0.0306.
  • Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) stock is projected to chart a bullish course in 2040, with an average price target of $2.6863, representing an $8,679% surge from its current level. The forecast ranges from a conservative $2.3098 to a sky-high $2.6863.
  • Our analysts predict Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) to jump 11,528% by 2045, soaring from $3.0929 to an average price of $3.5581, potentially reaching $3.5581. While $3.0929 is the low estimate, the potential upside is significant.
  • Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) stock is expected to climb by 2050, reaching an average of $4.3388, a $14,079% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.3388 and $3.9117, respectively, highlighting the market's uncertainty.

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) Year by Year Forecast

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) Price Forecast for 2025

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) is expected to reach an average price of $0.4391 in 2025, with a high prediction of $0.627 and a low estimate of $0.2512. This indicates an +1,335% rise from the last recorded price of $0.0306.
Month Average Low High Change from today's price
August, 2025 $0.2834 $0.2834 $0.559 +826.17%
September, 2025 $0.3811 $0.3236 $0.3826 +1,146%
October, 2025 $0.4798 $0.4194 $0.4798 +1,468%
November, 2025 $0.5382 $0.4886 $0.5382 +1,659%
December, 2025 $0.627 $0.5473 $0.627 +1,949%

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) Price Forecast for 2026

The predicted value for Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) in 2026 is set at an average of $0.5393. Estimates vary from a peak of $0.763 to a trough of $0.3156, indicating an +1,662% surge from the present price of $0.0306.
Month Average Low High Change from today's price
January, 2026 $0.3709 $0.3156 $0.6182 +1,112%
February, 2026 $0.4811 $0.3808 $0.4811 +1,472%
March, 2026 $0.559 $0.4655 $0.559 +1,727%
April, 2026 $0.6494 $0.5519 $0.6494 +2,022%
May, 2026 $0.6758 $0.6567 $0.695 +2,109%
June, 2026 $0.4539 $0.3478 $0.4629 +1,383%
July, 2026 $0.559 $0.4654 $0.559 +1,727%
August, 2026 $0.6187 $0.5565 $0.6187 +1,922%
September, 2026 $0.7353 $0.6508 $0.7353 +2,303%
October, 2026 $0.4261 $0.3799 $0.763 +1,293%
November, 2026 $0.5075 $0.4432 $0.5075 +1,559%
December, 2026 $0.6448 $0.5577 $0.6448 +2,007%

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) is $0.6902, with a high forecast of $0.9682 and a low forecast of $0.4121. This indicates an +2,155% increase from the last price of $0.0306.
Month Average Low High Change from today's price
January, 2027 $0.7358 $0.664 $0.7358 +2,305%
February, 2027 $0.831 $0.7568 $0.831 +2,616%
March, 2027 $0.5257 $0.4121 $0.8282 +1,618%
April, 2027 $0.6163 $0.5332 $0.6202 +1,914%
May, 2027 $0.7212 $0.6272 $0.7212 +2,257%
June, 2027 $0.8488 $0.7201 $0.8508 +2,674%
July, 2027 $0.4443 $0.4443 $0.8991 +1,352%
August, 2027 $0.5918 $0.4945 $0.5918 +1,834%
September, 2027 $0.7302 $0.65 $0.7302 +2,286%
October, 2027 $0.8285 $0.749 $0.8285 +2,607%
November, 2027 $0.9671 $0.8475 $0.9671 +3,060%
December, 2027 $0.5517 $0.4765 $0.9682 +1,703%

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) Price Forecast for 2028

In 2028, Algorae Pharmaceuticals Ltd Sponsored ADR (LVCLY) is projected to reach an average price of $0.8084, with a high projection of $1.1082 and a low estimate of $0.5086. This indicates an +2,542% rise from the last price of $0.0306.
Month Average Low High Change from today's price
January, 2028 $0.7017 $0.5716 $0.7017 +2,193%
February, 2028 $0.8294 $0.6961 $0.8294 +2,610%
March, 2028 $0.9596 $0.8322 $0.9596 +3,036%
April, 2028 $1.0075 $0.9768 $1.0382 +3,193%
May, 2028 $0.6546 $0.5086 $0.6636 +2,039%
June, 2028 $0.7995 $0.6761 $0.7995 +2,513%
July, 2028 $0.899 $0.807 $0.899 +2,838%
August, 2028 $1.0654 $0.9411 $1.0654 +3,382%
September, 2028 $0.597 $0.5408 $1.1082 +1,851%
October, 2028 $0.7899 $0.624 $0.7899 +2,482%
November, 2028 $0.9053 $0.7883 $0.9053 +2,858%
December, 2028 $1.036 $0.9375 $1.036 +3,286%

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) Price Forecast for 2029

The 2029 price forecast for Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) is $0.9456 on average, with a high prediction of $1.3182 and a low estimate of $0.573. This represents an +2,990% increase from the previous price of $0.0306.
Month Average Low High Change from today's price
January, 2029 $1.1226 $1.067 $1.1782 +3,569%
February, 2029 $0.7164 $0.573 $0.7164 +2,241%
March, 2029 $0.8468 $0.7339 $0.8507 +2,667%
April, 2029 $0.9916 $0.8678 $0.9916 +3,141%
May, 2029 $1.1689 $1.0004 $1.1709 +3,720%
June, 2029 $0.6052 $0.6052 $1.2482 +1,878%
July, 2029 $0.8025 $0.6653 $0.8025 +2,522%
August, 2029 $0.9807 $0.8782 $0.9807 +3,105%
September, 2029 $1.1188 $1.0094 $1.1188 +3,556%
October, 2029 $1.3071 $1.1478 $1.3071 +4,172%
November, 2029 $0.7325 $0.6373 $1.3182 +2,294%
December, 2029 $0.9223 $0.7623 $0.9223 +2,914%

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) Price Forecast for 2030

Algorae Pharmaceuticals Ltd Sponsored ADR Stock (LVCLY) is expected to reach an average price of $1.0989 in 2030, with a high forecast of $1.5283 and a low forecast of $0.6695. This signifies an +3,491% surge from the last price of $0.0306.
Month Average Low High Change from today's price
January, 2030 $1.0998 $0.9266 $1.0998 +3,494%
February, 2030 $1.2698 $1.1126 $1.2698 +4,050%
March, 2030 $1.3426 $1.297 $1.3883 +4,288%
April, 2030 $0.8553 $0.6695 $0.8643 +2,695%
May, 2030 $1.04 $0.8867 $1.04 +3,299%
June, 2030 $1.1793 $1.0574 $1.1793 +3,754%
July, 2030 $1.3955 $1.2314 $1.3955 +4,461%
August, 2030 $0.7678 $0.7017 $1.4583 +2,409%
September, 2030 $0.9288 $0.8048 $0.9288 +2,935%
October, 2030 $1.1657 $1.0106 $1.1657 +3,709%
November, 2030 $1.3363 $1.2079 $1.3363 +4,267%
December, 2030 $1.4528 $1.3772 $1.5283 +4,648%
$0.17
price up icon 5.50%
$0.66
price down icon 5.71%
$40.02
price down icon 0.27%
$94.70
price up icon 0.34%
$81.51
price up icon 0.49%
$50.44
price up icon 0.24%
Cap:     |  Volume (24h):